Searched for
LUNDBECK
Sun Pharma enters licensing pact with Lundbeck to launch novel anti-depressant pill in IndiaVortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in adults.- Lupin gets USFDA nod to market generic drugThe company has received approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Vigabatri...
- Drugmakers, device companies say sanctions may hinder medical supplies to RussiaSanctions levied by the US, Britain, Europe and Canada against Russia do not apply to medicine and medical equipment.
- Alembic Pharma gets tentative USFDA approval for depressive disorder drugCiting IQVIA data, the company said these Vortioxetine tablets have an estimated market size of USD 1,249 million for twelve months ending ...
- Danish pharma company Lundbeck downs shutters in IndiaThe $2.7 billion Lundbeck, which is based out of Bengaluru, has a sales and marketing team of around 100 people in the country.
- Aurobindo Pharma gets USFDA nod for generic Droxidopa capsulesThe company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Droxidopa capsules in th...
- Lupin gets USFDA nod for generic drugDrugmaker Lupin on Friday said it has received approval from the US health regulator to market Droxidopa capsules, used to treat dizziness....
- Aurobindo Pharma gets USFDA nod for generic Droxidopa capsulesThe company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Droxidopa capsules in th...
- Dr Reddy's launches generic oral anti-epileptic drug in USThe product is a generic version of Lundbeck's Sabril powder for oral solution, Dr Reddy's said in a filing to the BSE.
- Lupin launches generic seizure drug in USThe company has launched Clobazam tablets in the strengths of 10 mg and 20 mg, after having received an approval from the United States Foo...
- European shares dip as earnings disappointAmong top performers, Nokian Tyres jumped 5.5 per cent after beating earnings expectations and Dutch bank ABN Amro
- Depression taking toll on Chinese workforce: SurveySurvey shows staggering 70% of Chinese workforce diagnosed with depression reporting impaired performance;workers demand stringent legislat...
- Lundbeck to seek legal recourse after health ministry bans Deanxit againThe government had first banned the drug in June last year after noting that it was not approved for marketing in several developed markets.
- EU watchdog slaps fine on Ranbaxy for anti-competition deal over anti-depressantRanbaxy to appeal against the EU charges of delaying access to a generic version of a blockbuster anti-depressant.
- EC fines Ranbaxy, others for blocking cheaper drugsEC imposed a fine of 146 million euros on nine pharma companies, including Ranbaxy Laboratories, for delaying market entry of cheaper gener...
- EU regulators to fine Ranbaxy, Merck, others: SourcesThe European Union’s Anti-Trust Commission may impose a fine on Ranbaxy Labs among other generic and innovator firms, including Denmark-bas...
- Govt to seek safety test on antianxiety drug DeanxitThe drug technical advisory board (DTAB) had put the drug under review due to complaints of side effects and approval without mandatory stu...
- Sun's Caraco settles litigation with Forest Lab in USThe Rs 4,300-crore Sun Pharmaceuticals Ltd's US-subsidiary, Caraco Pharmaceuticals Laboratories Ltd, has gone for settlement of the legal p...
- Sun Pharma enters pact with Forest Labs,H Lundbeck for LexaproSun Pharma and its US subsidiary Caraco Pharma have entered into agreements with Forest Laboratoriesa and H Lundbeck to settle legal procee...
- Shasun Pharma, Lundbeck in tech collabShasun Pharma inks licensing agreement with Danish Lundbeck for technology sharing.
Load More
